Naturalle Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.22 M
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 2.00 M
About Naturalle Biotech
Naturalle Biotech Pvt. Ltd. (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 1992 and has a history of 32 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.22 M.
The company has closed loans amounting to ₹2.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashok Waghray and Vijaya Waghray serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U73100TG1992PTC014743
- Company No.
014743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1992
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Naturalle Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Waghray  | Managing Director | 11-Sep-1992 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Waghray | Director | 24-Apr-2004 | Current |
Financial Performance of Naturalle Biotech.
Enhance accessibility to Naturalle Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Naturalle Biotech?
In 2016, Naturalle Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pranava Chemi Processors Private LimitedAshok Waghray and Vijaya Waghray are mutual person
Charges (Loans)
₹0
₹2.00 M
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2000 | State Bank Of Hyderabad | ₹0.50 M | Satisfied |
| 04 Oct 2000 | State Bank Of Hyderabad | ₹1.50 M | Satisfied |
How Many Employees Work at Naturalle Biotech?
Unlock and access historical data on people associated with Naturalle Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naturalle Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naturalle Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.